Influenza, commonly known as the flu, is an infectious disease caused by an influenza virus.
This report contains market size and forecasts of Influenza Therapeutics in Global, including the following market information:
Global Influenza Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Influenza Therapeutics market was valued at 6836.6 million in 2021 and is projected to reach US$ 9362.1 million by 2028, at a CAGR of 4.6% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Vaccines Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Influenza Therapeutics include Abbott Laboratories, Astrazeneca PLC, Biocryst Pharmaceuticals, Inc., Chiron Corporation, CSL Limited, Daiichi Sankyo Co., Ltd., Glaxosmithkline PLC, Mitsubishi Tanabe Pharma Corporation and Nanotherapeutics Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Influenza Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Influenza Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Influenza Therapeutics Market Segment Percentages, by Type, 2021 (%)
Vaccines
Drugs
Global Influenza Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Influenza Therapeutics Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinic
Others
Global Influenza Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Influenza Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Influenza Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Influenza Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Astrazeneca PLC
Biocryst Pharmaceuticals, Inc.
Chiron Corporation
CSL Limited
Daiichi Sankyo Co., Ltd.
Glaxosmithkline PLC
Mitsubishi Tanabe Pharma Corporation
Nanotherapeutics Inc.
Protein Sciences Corporation
Roche Holding AG
Sanofi SA
Shionogi & Co., Ltd.
Sinovac Biotech Ltd.